The Accountability Blog

Day: August 26, 2016

EpiPen Doesn’t Stick To Their Values – They Stick it to Their Customers

Mylan, the manufacturer of the EpiPen used by children and adults with deadly allergies, has raised the price of this lifesaving device from $100 to $600 since they acquired it in 2007.

Since when does the actions of other people justify our actions? Since when does the actions of other companies justify our company’s actions? And, when does someone step up and say, “We’re going to do what’s right, period”?

Read More »

We use cookies to give you the best online experience.
By using our website, you agree to our use of cookies in accordance with our privacy policy